Review



cd3 positive selection kit  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Miltenyi Biotec cd3 positive selection kit
    Cd3 Positive Selection Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd19+positive+selection+kit/MACSprep+CD3+and+CD19+Selection+Kit%2C+human/pmc10362418__mmc4-422-65-69
    Average 94 stars, based on 2 article reviews
    cd3 positive selection kit - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Purification:

    Article Title: Blockade of B-cell activating factor (BAFF) reshapes the hepatic B cell receptor repertoire and attenuates autoantibody production in cholestatic liver disease
    Article Snippet: .. B cells were purified by using CD19-positive selection kit (Miltenyi). .. For staining, following antibodies were used: anti-CD19 (1D3), CD3 (17A2), CD4 (RM4-5), CD8 (53-6.7), CD11b (M1/70), CD11c (N418), Ly6C (HK1.4), GR1 (RB6-8C5), I/A-I/E (M5/114.15.2), CD45.1 (A20) (Tonbo Biosciences, USA).

    Article Title: The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis
    Article Snippet: .. Healthy blood cells were purified from the peripheral blood mononuclear cells of healthy donors (EFS [Etablissement Français du Sang, Nantes, France]) using either an untouched PanT isolation kit (Miltenyi Bergisch Gladbach, Germany, ref 130-096-535) for T lymphocytes, a CD19 positive selection kit (Miltenyi, ref 130-050-301) for B lymphocytes or an untouched NK isolation kit (Miltenyi ref 130-092-657) for NK cells, following manufacturer’s instructions. ..

    Selection:

    Article Title: Blockade of B-cell activating factor (BAFF) reshapes the hepatic B cell receptor repertoire and attenuates autoantibody production in cholestatic liver disease
    Article Snippet: .. B cells were purified by using CD19-positive selection kit (Miltenyi). .. For staining, following antibodies were used: anti-CD19 (1D3), CD3 (17A2), CD4 (RM4-5), CD8 (53-6.7), CD11b (M1/70), CD11c (N418), Ly6C (HK1.4), GR1 (RB6-8C5), I/A-I/E (M5/114.15.2), CD45.1 (A20) (Tonbo Biosciences, USA).

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM+/IgD+ mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    Article Title: The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis
    Article Snippet: .. Healthy blood cells were purified from the peripheral blood mononuclear cells of healthy donors (EFS [Etablissement Français du Sang, Nantes, France]) using either an untouched PanT isolation kit (Miltenyi Bergisch Gladbach, Germany, ref 130-096-535) for T lymphocytes, a CD19 positive selection kit (Miltenyi, ref 130-050-301) for B lymphocytes or an untouched NK isolation kit (Miltenyi ref 130-092-657) for NK cells, following manufacturer’s instructions. ..

    Article Title: Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma
    Article Snippet: .. Human CD19 + B-cells were isolated from cell suspensions using CD19 positive selection kit and AutoMACS Pro Separator (Miltenyi Biotech, USA) according to the kit's instructions. ..

    Article Title: Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
    Article Snippet: .. Human CD19 + B-cells were isolated from cell suspensions using CD19 positive selection kit and AutoMACS Pro Separator (Miltenyi Biotech, USA) according to the kit instructions. ..

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM/IgD mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    other:

    Article Title: Blockade of B-cell activating factor (BAFF) reshapes the hepatic B cell receptor repertoire and attenuates autoantibody production in cholestatic liver disease
    Article Snippet: For staining, following antibodies were used: anti-CD19 (1D3), CD3 (17A2), CD4 (RM4-5), CD8 (53-6.7), CD11b (M1/70), CD11c (N418), Ly6C (HK1.4), GR1 (RB6-8C5), I/A-I/E (M5/114.15.2), CD45.1 (A20) (Tonbo Biosciences, USA).

    Article Title: TLR9 and IL1R1 promote mobilization of pulmonary dendritic cells during beryllium sensitization
    Article Snippet: 10 5 CD4 + T cells were co-cultured with 10 5 B cells in cRPMI media +/− 100 μM BeSO 4 on coated and blocked IL-2 or IFNγ ELISPOT plates overnight and the number of spots was determined as previously described ( 13 ) using ImmunoSpot Reader and software (CTL).

    Isolation:

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM+/IgD+ mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    Article Title: The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis
    Article Snippet: .. Healthy blood cells were purified from the peripheral blood mononuclear cells of healthy donors (EFS [Etablissement Français du Sang, Nantes, France]) using either an untouched PanT isolation kit (Miltenyi Bergisch Gladbach, Germany, ref 130-096-535) for T lymphocytes, a CD19 positive selection kit (Miltenyi, ref 130-050-301) for B lymphocytes or an untouched NK isolation kit (Miltenyi ref 130-092-657) for NK cells, following manufacturer’s instructions. ..

    Article Title: Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma
    Article Snippet: .. Human CD19 + B-cells were isolated from cell suspensions using CD19 positive selection kit and AutoMACS Pro Separator (Miltenyi Biotech, USA) according to the kit's instructions. ..

    Article Title: Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
    Article Snippet: .. Human CD19 + B-cells were isolated from cell suspensions using CD19 positive selection kit and AutoMACS Pro Separator (Miltenyi Biotech, USA) according to the kit instructions. ..

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM/IgD mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    Fluorescence:

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM+/IgD+ mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM/IgD mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    FACS:

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM+/IgD+ mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM/IgD mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    Flow Cytometry:

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM+/IgD+ mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..

    Article Title: Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.
    Article Snippet: .. The correct text is as follows: ‘Splenic IgM/IgD mature B cells were isolated using a CD19-positive selection kit [Miltenyi Biotec (130-121-301), 90–95% purity as determined by fluorescence-activated cell sorting (FACS)] and immature IgM+/IgD− B cells were isolated and collected by flow cytometry.’ The authors apologise to readers for this error, which does not impact the results or the conclusions of the article. ..



    Similar Products

    cd3 positive selection kit  (Miltenyi Biotec)
    94
    Miltenyi Biotec cd3 positive selection kit
    Cd3 Positive Selection Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd19+positive+selection+kit/MACSprep+CD3+and+CD19+Selection+Kit%2C+human/pmc10362418__mmc4-422-65-69
    Average 94 stars, based on 1 article reviews
    cd3 positive selection kit - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    easysep immunomagnetic cd19 positive selection kit  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easysep immunomagnetic cd19 positive selection kit
    (A) Representative contour plots and cumulative data showing the frequencies of <t>CD19</t> + CD27 - IgD - (double negative (DN)), CD19 + CD27 + IgD - , CD19 + CD27 + IgD + (unswitched memory (USM)) and CD19 + CD27 - IgD + (naive) B cells ex vivo in paired BK and matching tumor tissue; ** p <0.01, *** p <0.001. n= 32 biologically independent samples. DN, USM, and naive B cells analyzed by paired two-tailed Student’s t -test, CD19 + CD27 + IgD - B cells analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (B) Representative contour plots and cumulative data showing the frequencies of CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) and BLIMP-1 + B cells ex vivo in paired BK and matching tumor tissue. BLIMP-1 expression overlaid onto the B cell contour plot; ** p <0.01, **** p <0.0001. For plasma cells n =31 and for BLIMP-1 + B cells n =15 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (C) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 + IgD - CD24 + CD38 - IgM + (IgM + memory) and CD19 + CD27 + IgD - CD24 + CD38 - IgM - (class-switched memory (CSM)) B cells ex vivo in paired BK and tumor; *** p <0.001. n= 32 biologically independent samples. CSM analyzed by paired two-tailed Student’s t -test, IgM + memory analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + CD24 int CD38 int (mature) and CD19 + CD27 - IgD + CD24 hi CD38 hi transitional B cells ex vivo in paired BK and tumor. n= 32 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3), and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells ex vivo in BK and tumor; ** p <0.01. n= 18 biologically independent samples. Paired two-tailed Student’s t -test. Error bars represented as mean±SEM. (F) Cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD - , CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) B cells, and CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) stratified according to intermediate (3-5) or high (>6) Leibovich scores; * p <0.05, ** p <0.01. For naive, CD27 + IgD - , and plasma cells n= 26, for DN1 and DN3 n= 13 biologically independent samples. Naive, DN1, DN3, and PC analyzed by unpaired two-tailed Student’s t -test, CD27 + IgD - analyzed by unpaired Mann-Whitney U test. Error bars represented as mean±SEM.
    Easysep Immunomagnetic Cd19 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd19+positive+selection+kit/easysep+human+t+cell+isolation+kit/bio_rxiv__2025__07__08__663720-197-7-13
    Average 90 stars, based on 1 article reviews
    easysep immunomagnetic cd19 positive selection kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    easysep release human cd19 positive selection kit  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easysep release human cd19 positive selection kit
    (A) Representative contour plots and cumulative data showing the frequencies of <t>CD19</t> + CD27 - IgD - (double negative (DN)), CD19 + CD27 + IgD - , CD19 + CD27 + IgD + (unswitched memory (USM)) and CD19 + CD27 - IgD + (naive) B cells ex vivo in paired BK and matching tumor tissue; ** p <0.01, *** p <0.001. n= 32 biologically independent samples. DN, USM, and naive B cells analyzed by paired two-tailed Student’s t -test, CD19 + CD27 + IgD - B cells analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (B) Representative contour plots and cumulative data showing the frequencies of CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) and BLIMP-1 + B cells ex vivo in paired BK and matching tumor tissue. BLIMP-1 expression overlaid onto the B cell contour plot; ** p <0.01, **** p <0.0001. For plasma cells n =31 and for BLIMP-1 + B cells n =15 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (C) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 + IgD - CD24 + CD38 - IgM + (IgM + memory) and CD19 + CD27 + IgD - CD24 + CD38 - IgM - (class-switched memory (CSM)) B cells ex vivo in paired BK and tumor; *** p <0.001. n= 32 biologically independent samples. CSM analyzed by paired two-tailed Student’s t -test, IgM + memory analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + CD24 int CD38 int (mature) and CD19 + CD27 - IgD + CD24 hi CD38 hi transitional B cells ex vivo in paired BK and tumor. n= 32 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3), and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells ex vivo in BK and tumor; ** p <0.01. n= 18 biologically independent samples. Paired two-tailed Student’s t -test. Error bars represented as mean±SEM. (F) Cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD - , CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) B cells, and CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) stratified according to intermediate (3-5) or high (>6) Leibovich scores; * p <0.05, ** p <0.01. For naive, CD27 + IgD - , and plasma cells n= 26, for DN1 and DN3 n= 13 biologically independent samples. Naive, DN1, DN3, and PC analyzed by unpaired two-tailed Student’s t -test, CD27 + IgD - analyzed by unpaired Mann-Whitney U test. Error bars represented as mean±SEM.
    Easysep Release Human Cd19 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd19+positive+selection+kit/easysep+human+t+cell+isolation+kit/pm40614737-416-11-18
    Average 90 stars, based on 1 article reviews
    easysep release human cd19 positive selection kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    easysep human cd19 positive selection kit ii  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easysep human cd19 positive selection kit ii
    (A) Representative contour plots and cumulative data showing the frequencies of <t>CD19</t> + CD27 - IgD - (double negative (DN)), CD19 + CD27 + IgD - , CD19 + CD27 + IgD + (unswitched memory (USM)) and CD19 + CD27 - IgD + (naive) B cells ex vivo in paired BK and matching tumor tissue; ** p <0.01, *** p <0.001. n= 32 biologically independent samples. DN, USM, and naive B cells analyzed by paired two-tailed Student’s t -test, CD19 + CD27 + IgD - B cells analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (B) Representative contour plots and cumulative data showing the frequencies of CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) and BLIMP-1 + B cells ex vivo in paired BK and matching tumor tissue. BLIMP-1 expression overlaid onto the B cell contour plot; ** p <0.01, **** p <0.0001. For plasma cells n =31 and for BLIMP-1 + B cells n =15 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (C) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 + IgD - CD24 + CD38 - IgM + (IgM + memory) and CD19 + CD27 + IgD - CD24 + CD38 - IgM - (class-switched memory (CSM)) B cells ex vivo in paired BK and tumor; *** p <0.001. n= 32 biologically independent samples. CSM analyzed by paired two-tailed Student’s t -test, IgM + memory analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + CD24 int CD38 int (mature) and CD19 + CD27 - IgD + CD24 hi CD38 hi transitional B cells ex vivo in paired BK and tumor. n= 32 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3), and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells ex vivo in BK and tumor; ** p <0.01. n= 18 biologically independent samples. Paired two-tailed Student’s t -test. Error bars represented as mean±SEM. (F) Cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD - , CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) B cells, and CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) stratified according to intermediate (3-5) or high (>6) Leibovich scores; * p <0.05, ** p <0.01. For naive, CD27 + IgD - , and plasma cells n= 26, for DN1 and DN3 n= 13 biologically independent samples. Naive, DN1, DN3, and PC analyzed by unpaired two-tailed Student’s t -test, CD27 + IgD - analyzed by unpaired Mann-Whitney U test. Error bars represented as mean±SEM.
    Easysep Human Cd19 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd19+positive+selection+kit/easysep+human+t+cell+isolation+kit/pmc12164974-229-13-20
    Average 90 stars, based on 1 article reviews
    easysep human cd19 positive selection kit ii - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    easyseptm human cd19 positive selection kit ii  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easyseptm human cd19 positive selection kit ii
    (A) Representative contour plots and cumulative data showing the frequencies of <t>CD19</t> + CD27 - IgD - (double negative (DN)), CD19 + CD27 + IgD - , CD19 + CD27 + IgD + (unswitched memory (USM)) and CD19 + CD27 - IgD + (naive) B cells ex vivo in paired BK and matching tumor tissue; ** p <0.01, *** p <0.001. n= 32 biologically independent samples. DN, USM, and naive B cells analyzed by paired two-tailed Student’s t -test, CD19 + CD27 + IgD - B cells analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (B) Representative contour plots and cumulative data showing the frequencies of CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) and BLIMP-1 + B cells ex vivo in paired BK and matching tumor tissue. BLIMP-1 expression overlaid onto the B cell contour plot; ** p <0.01, **** p <0.0001. For plasma cells n =31 and for BLIMP-1 + B cells n =15 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (C) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 + IgD - CD24 + CD38 - IgM + (IgM + memory) and CD19 + CD27 + IgD - CD24 + CD38 - IgM - (class-switched memory (CSM)) B cells ex vivo in paired BK and tumor; *** p <0.001. n= 32 biologically independent samples. CSM analyzed by paired two-tailed Student’s t -test, IgM + memory analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + CD24 int CD38 int (mature) and CD19 + CD27 - IgD + CD24 hi CD38 hi transitional B cells ex vivo in paired BK and tumor. n= 32 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3), and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells ex vivo in BK and tumor; ** p <0.01. n= 18 biologically independent samples. Paired two-tailed Student’s t -test. Error bars represented as mean±SEM. (F) Cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD - , CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) B cells, and CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) stratified according to intermediate (3-5) or high (>6) Leibovich scores; * p <0.05, ** p <0.01. For naive, CD27 + IgD - , and plasma cells n= 26, for DN1 and DN3 n= 13 biologically independent samples. Naive, DN1, DN3, and PC analyzed by unpaired two-tailed Student’s t -test, CD27 + IgD - analyzed by unpaired Mann-Whitney U test. Error bars represented as mean±SEM.
    Easyseptm Human Cd19 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd19+positive+selection+kit/easysep+human+t+cell+isolation+kit/pm40499670-61-22-29
    Average 90 stars, based on 1 article reviews
    easyseptm human cd19 positive selection kit ii - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    easyseptm mouse cd19 positive selection kit  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easyseptm mouse cd19 positive selection kit
    (A) Representative contour plots and cumulative data showing the frequencies of <t>CD19</t> + CD27 - IgD - (double negative (DN)), CD19 + CD27 + IgD - , CD19 + CD27 + IgD + (unswitched memory (USM)) and CD19 + CD27 - IgD + (naive) B cells ex vivo in paired BK and matching tumor tissue; ** p <0.01, *** p <0.001. n= 32 biologically independent samples. DN, USM, and naive B cells analyzed by paired two-tailed Student’s t -test, CD19 + CD27 + IgD - B cells analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (B) Representative contour plots and cumulative data showing the frequencies of CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) and BLIMP-1 + B cells ex vivo in paired BK and matching tumor tissue. BLIMP-1 expression overlaid onto the B cell contour plot; ** p <0.01, **** p <0.0001. For plasma cells n =31 and for BLIMP-1 + B cells n =15 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (C) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 + IgD - CD24 + CD38 - IgM + (IgM + memory) and CD19 + CD27 + IgD - CD24 + CD38 - IgM - (class-switched memory (CSM)) B cells ex vivo in paired BK and tumor; *** p <0.001. n= 32 biologically independent samples. CSM analyzed by paired two-tailed Student’s t -test, IgM + memory analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + CD24 int CD38 int (mature) and CD19 + CD27 - IgD + CD24 hi CD38 hi transitional B cells ex vivo in paired BK and tumor. n= 32 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3), and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells ex vivo in BK and tumor; ** p <0.01. n= 18 biologically independent samples. Paired two-tailed Student’s t -test. Error bars represented as mean±SEM. (F) Cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD - , CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) B cells, and CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) stratified according to intermediate (3-5) or high (>6) Leibovich scores; * p <0.05, ** p <0.01. For naive, CD27 + IgD - , and plasma cells n= 26, for DN1 and DN3 n= 13 biologically independent samples. Naive, DN1, DN3, and PC analyzed by unpaired two-tailed Student’s t -test, CD27 + IgD - analyzed by unpaired Mann-Whitney U test. Error bars represented as mean±SEM.
    Easyseptm Mouse Cd19 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd19+positive+selection+kit/easysep+human+t+cell+isolation+kit/pm40250016-217-24-30
    Average 90 stars, based on 1 article reviews
    easyseptm mouse cd19 positive selection kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    easysep mouse cd19 positive selection kit ii  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easysep mouse cd19 positive selection kit ii
    (A) Representative contour plots and cumulative data showing the frequencies of <t>CD19</t> + CD27 - IgD - (double negative (DN)), CD19 + CD27 + IgD - , CD19 + CD27 + IgD + (unswitched memory (USM)) and CD19 + CD27 - IgD + (naive) B cells ex vivo in paired BK and matching tumor tissue; ** p <0.01, *** p <0.001. n= 32 biologically independent samples. DN, USM, and naive B cells analyzed by paired two-tailed Student’s t -test, CD19 + CD27 + IgD - B cells analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (B) Representative contour plots and cumulative data showing the frequencies of CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) and BLIMP-1 + B cells ex vivo in paired BK and matching tumor tissue. BLIMP-1 expression overlaid onto the B cell contour plot; ** p <0.01, **** p <0.0001. For plasma cells n =31 and for BLIMP-1 + B cells n =15 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (C) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 + IgD - CD24 + CD38 - IgM + (IgM + memory) and CD19 + CD27 + IgD - CD24 + CD38 - IgM - (class-switched memory (CSM)) B cells ex vivo in paired BK and tumor; *** p <0.001. n= 32 biologically independent samples. CSM analyzed by paired two-tailed Student’s t -test, IgM + memory analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + CD24 int CD38 int (mature) and CD19 + CD27 - IgD + CD24 hi CD38 hi transitional B cells ex vivo in paired BK and tumor. n= 32 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3), and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells ex vivo in BK and tumor; ** p <0.01. n= 18 biologically independent samples. Paired two-tailed Student’s t -test. Error bars represented as mean±SEM. (F) Cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD - , CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) B cells, and CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) stratified according to intermediate (3-5) or high (>6) Leibovich scores; * p <0.05, ** p <0.01. For naive, CD27 + IgD - , and plasma cells n= 26, for DN1 and DN3 n= 13 biologically independent samples. Naive, DN1, DN3, and PC analyzed by unpaired two-tailed Student’s t -test, CD27 + IgD - analyzed by unpaired Mann-Whitney U test. Error bars represented as mean±SEM.
    Easysep Mouse Cd19 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd19+positive+selection+kit/easysep+human+t+cell+isolation+kit/pm39943808-201-18-25
    Average 90 stars, based on 1 article reviews
    easysep mouse cd19 positive selection kit ii - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - (double negative (DN)), CD19 + CD27 + IgD - , CD19 + CD27 + IgD + (unswitched memory (USM)) and CD19 + CD27 - IgD + (naive) B cells ex vivo in paired BK and matching tumor tissue; ** p <0.01, *** p <0.001. n= 32 biologically independent samples. DN, USM, and naive B cells analyzed by paired two-tailed Student’s t -test, CD19 + CD27 + IgD - B cells analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (B) Representative contour plots and cumulative data showing the frequencies of CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) and BLIMP-1 + B cells ex vivo in paired BK and matching tumor tissue. BLIMP-1 expression overlaid onto the B cell contour plot; ** p <0.01, **** p <0.0001. For plasma cells n =31 and for BLIMP-1 + B cells n =15 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (C) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 + IgD - CD24 + CD38 - IgM + (IgM + memory) and CD19 + CD27 + IgD - CD24 + CD38 - IgM - (class-switched memory (CSM)) B cells ex vivo in paired BK and tumor; *** p <0.001. n= 32 biologically independent samples. CSM analyzed by paired two-tailed Student’s t -test, IgM + memory analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + CD24 int CD38 int (mature) and CD19 + CD27 - IgD + CD24 hi CD38 hi transitional B cells ex vivo in paired BK and tumor. n= 32 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3), and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells ex vivo in BK and tumor; ** p <0.01. n= 18 biologically independent samples. Paired two-tailed Student’s t -test. Error bars represented as mean±SEM. (F) Cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD - , CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) B cells, and CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) stratified according to intermediate (3-5) or high (>6) Leibovich scores; * p <0.05, ** p <0.01. For naive, CD27 + IgD - , and plasma cells n= 26, for DN1 and DN3 n= 13 biologically independent samples. Naive, DN1, DN3, and PC analyzed by unpaired two-tailed Student’s t -test, CD27 + IgD - analyzed by unpaired Mann-Whitney U test. Error bars represented as mean±SEM.

    Journal: bioRxiv

    Article Title: Tumor-infiltrating CD27 - IgD - regulatory B cells suppress cytotoxic CD8 + T cell responses in renal cell carcinoma

    doi: 10.1101/2025.07.08.663720

    Figure Lengend Snippet: (A) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - (double negative (DN)), CD19 + CD27 + IgD - , CD19 + CD27 + IgD + (unswitched memory (USM)) and CD19 + CD27 - IgD + (naive) B cells ex vivo in paired BK and matching tumor tissue; ** p <0.01, *** p <0.001. n= 32 biologically independent samples. DN, USM, and naive B cells analyzed by paired two-tailed Student’s t -test, CD19 + CD27 + IgD - B cells analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (B) Representative contour plots and cumulative data showing the frequencies of CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) and BLIMP-1 + B cells ex vivo in paired BK and matching tumor tissue. BLIMP-1 expression overlaid onto the B cell contour plot; ** p <0.01, **** p <0.0001. For plasma cells n =31 and for BLIMP-1 + B cells n =15 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (C) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 + IgD - CD24 + CD38 - IgM + (IgM + memory) and CD19 + CD27 + IgD - CD24 + CD38 - IgM - (class-switched memory (CSM)) B cells ex vivo in paired BK and tumor; *** p <0.001. n= 32 biologically independent samples. CSM analyzed by paired two-tailed Student’s t -test, IgM + memory analyzed by paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + CD24 int CD38 int (mature) and CD19 + CD27 - IgD + CD24 hi CD38 hi transitional B cells ex vivo in paired BK and tumor. n= 32 biologically independent samples. Paired two-tailed Wilcoxon test. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3), and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells ex vivo in BK and tumor; ** p <0.01. n= 18 biologically independent samples. Paired two-tailed Student’s t -test. Error bars represented as mean±SEM. (F) Cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD - , CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) B cells, and CD19 + CD24 lo/- CD38 hi (plasma cells (PCs)) stratified according to intermediate (3-5) or high (>6) Leibovich scores; * p <0.05, ** p <0.01. For naive, CD27 + IgD - , and plasma cells n= 26, for DN1 and DN3 n= 13 biologically independent samples. Naive, DN1, DN3, and PC analyzed by unpaired two-tailed Student’s t -test, CD27 + IgD - analyzed by unpaired Mann-Whitney U test. Error bars represented as mean±SEM.

    Article Snippet: Tissue-resident B cells were isolated using the EasySep immunomagnetic CD19 positive selection kit (STEMCELL, cat. no. 17854).

    Techniques: Ex Vivo, Two Tailed Test, Clinical Proteomics, Expressing, MANN-WHITNEY

    (A) Density UMAPs showing the distribution of IL10 hi , TGFB hi , TXN hi , AHR hi , HAVCR2 hi , TIGIT hi , CD274 hi and PDCD1 hi RCC-resident B cells. (B) Dotplot showing the proportion of cells expressing a Breg score comprising IL10, CD274, AHR, TXN, LAG3, TIGIT, CTLA4, CD86, TGFB1, and GZMB (dot size), and their average expression levels (color intensity) in the tumor, tumor margin, BK, and blood. (C) Spatial analysis of segmented CD20 + Bregs in a representative TLS. Staining of DAPI (dark blue) overlaid with cell segmentation (gating strategy shown in Figure S5A) of CD20 + IL-10 + Bregs (red), CD20 + TGFβ + Bregs (green), and CD20 + IL-10 + TGFβ + Bregs (orange). Scale bar = 100µm. (D) Cumulative data showing the frequencies of CD20 + IL-10 + Bregs, CD20 + TGFβ + Bregs, CD20 + IL-10 + TGFβ + within ROIs; * p <0.05, ** p <0.01. 13 ROIs across n =3 biologically independent samples. One-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (E) Spatial analysis of segmented CD138 + Bregs in a representative TLS. Staining of DAPI (dark blue) overlaid with cell segmentation (gating strategy shown in Figure S5A) of CD138 + IL-10 + Bregs (pink), CD138 + TGFβ + Bregs (dark green), and CD138 + IL-10 + TGFβ + Bregs (yellow) within TLSs. (F) Cumulative data showing the frequencies of CD138 + IL-10 + Bregs, CD20 + CD138 + TGFβ + Bregs, CD138 + IL-10 + TGFβ + Bregs within ROIs; * p <0.05, ** p <0.01. 13 ROIs across n =3 biologically independent samples. One-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (G) Cumulative data showing the frequencies of CD20 + CD27 - IgD + (naive), CD20 + CD27 + IgD + (unswitched memory (USM)), CD20 + CD27 + IgD - B cells, CD20 + CD27 - IgD - CD21 + CD11c - (DN1), CD20 + CD27 - IgD - CD21 - CD11c + (DN2), CD20 + CD27 - IgD - CD21 - CD11c - (DN3), and CD20 + CD27 - IgD - CD21 + CD11c + (DN4) within CD20 + IL-10 + Bregs; * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. 13 ROIs across n =3 biologically independent samples. Fridman test with Dunn’s test for multiple comparisons. Error bars represented as mean±SEM. (H) Cumulative data showing the frequencies of CD20 + CD27 - IgD + (naive), CD20 + CD27 + IgD + (unswitched memory (USM)), CD20 + CD27 - IgD - (double negative (DN)), CD20 + CD27 + IgD - B cells, CD20 + CD27 - IgD - CD21 + CD11c - (DN1), CD20 + CD27 - IgD - CD21 - CD11c + (DN2), CD20 + CD27 - IgD - CD21 - CD11c - (DN3), and CD20 + CD27 - IgD - CD21 + CD11c + (DN4) B cells within CD20 + TGFβ + Bregs; * p <0.05, ** p <0.01. 13 ROIs across n =3 biologically independent samples. Fridman test with Dunn’s test for multiple comparisons. Error bars represented as mean±SEM. (I) Prognostic association of high versus low CD19, IL-10, TGFB1 signature with survival in RCC using The Cancer Genome Atlas (TCGA) data. p values were derived by Cox proportional hazard model adjusting for signature group, age, sex, and American Joint Committee on Cancer (AJCC) stage.

    Journal: bioRxiv

    Article Title: Tumor-infiltrating CD27 - IgD - regulatory B cells suppress cytotoxic CD8 + T cell responses in renal cell carcinoma

    doi: 10.1101/2025.07.08.663720

    Figure Lengend Snippet: (A) Density UMAPs showing the distribution of IL10 hi , TGFB hi , TXN hi , AHR hi , HAVCR2 hi , TIGIT hi , CD274 hi and PDCD1 hi RCC-resident B cells. (B) Dotplot showing the proportion of cells expressing a Breg score comprising IL10, CD274, AHR, TXN, LAG3, TIGIT, CTLA4, CD86, TGFB1, and GZMB (dot size), and their average expression levels (color intensity) in the tumor, tumor margin, BK, and blood. (C) Spatial analysis of segmented CD20 + Bregs in a representative TLS. Staining of DAPI (dark blue) overlaid with cell segmentation (gating strategy shown in Figure S5A) of CD20 + IL-10 + Bregs (red), CD20 + TGFβ + Bregs (green), and CD20 + IL-10 + TGFβ + Bregs (orange). Scale bar = 100µm. (D) Cumulative data showing the frequencies of CD20 + IL-10 + Bregs, CD20 + TGFβ + Bregs, CD20 + IL-10 + TGFβ + within ROIs; * p <0.05, ** p <0.01. 13 ROIs across n =3 biologically independent samples. One-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (E) Spatial analysis of segmented CD138 + Bregs in a representative TLS. Staining of DAPI (dark blue) overlaid with cell segmentation (gating strategy shown in Figure S5A) of CD138 + IL-10 + Bregs (pink), CD138 + TGFβ + Bregs (dark green), and CD138 + IL-10 + TGFβ + Bregs (yellow) within TLSs. (F) Cumulative data showing the frequencies of CD138 + IL-10 + Bregs, CD20 + CD138 + TGFβ + Bregs, CD138 + IL-10 + TGFβ + Bregs within ROIs; * p <0.05, ** p <0.01. 13 ROIs across n =3 biologically independent samples. One-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (G) Cumulative data showing the frequencies of CD20 + CD27 - IgD + (naive), CD20 + CD27 + IgD + (unswitched memory (USM)), CD20 + CD27 + IgD - B cells, CD20 + CD27 - IgD - CD21 + CD11c - (DN1), CD20 + CD27 - IgD - CD21 - CD11c + (DN2), CD20 + CD27 - IgD - CD21 - CD11c - (DN3), and CD20 + CD27 - IgD - CD21 + CD11c + (DN4) within CD20 + IL-10 + Bregs; * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. 13 ROIs across n =3 biologically independent samples. Fridman test with Dunn’s test for multiple comparisons. Error bars represented as mean±SEM. (H) Cumulative data showing the frequencies of CD20 + CD27 - IgD + (naive), CD20 + CD27 + IgD + (unswitched memory (USM)), CD20 + CD27 - IgD - (double negative (DN)), CD20 + CD27 + IgD - B cells, CD20 + CD27 - IgD - CD21 + CD11c - (DN1), CD20 + CD27 - IgD - CD21 - CD11c + (DN2), CD20 + CD27 - IgD - CD21 - CD11c - (DN3), and CD20 + CD27 - IgD - CD21 + CD11c + (DN4) B cells within CD20 + TGFβ + Bregs; * p <0.05, ** p <0.01. 13 ROIs across n =3 biologically independent samples. Fridman test with Dunn’s test for multiple comparisons. Error bars represented as mean±SEM. (I) Prognostic association of high versus low CD19, IL-10, TGFB1 signature with survival in RCC using The Cancer Genome Atlas (TCGA) data. p values were derived by Cox proportional hazard model adjusting for signature group, age, sex, and American Joint Committee on Cancer (AJCC) stage.

    Article Snippet: Tissue-resident B cells were isolated using the EasySep immunomagnetic CD19 positive selection kit (STEMCELL, cat. no. 17854).

    Techniques: Expressing, Staining, Derivative Assay

    (A) Radar plot showing the Human Molecular Signatures Database and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched in each tumor-infiltrating B cell (TIB) cluster. (B) Density UMAPs showing the distribution of TLR7 hi , TLR9 hi , MYD88 hi , IRAK1 hi , IRAK4 hi , TRAF6 hi , MAP3K7 hi , and NFKB1 hi RCC-resident B cells. (C) Representative contour plots and cumulative data showing IL-10 expression by tumor-infiltrating CD19 + B cells ex vivo (white) and following 72h stimulation with R848 (light grey) or CpGC (dark grey); ** p <0.01, *** p <0.001. For ex vivo n =16, R848 and CpGC n =22 biologically independent samples. Mixed-effects one-way ANOVA with Dunnett’s test for multiple comparisons. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing TGFβ expression by tumor-infiltrating CD19 + B cells ex vivo (white) and following 72h stimulation with R848 (light grey) or CpGC (dark grey); * p <0.05, ** p <0.01. For ex vivo n =13, R848 and CpGC n =10 biologically independent samples. One-way Fridman test with Dunn’s test for multiple comparisons. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD + (unswitched memory (USM)), CD19 + CD27 + IgD - , and CD19 + CD27 - IgD - (double negative (DN)) B cells within tumor-infiltrating CD19 + IL-10 + B cells, ex vivo and following 72h stimulation with R848 or CpGC; * p <0.05, ** p <0.01, **** p <0.0001. n =24 biologically independent samples. Two-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (F) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells within tumor-infiltrating CD19 + IL-10 + B cells, ex vivo and following 72h stimulation with R848 or CpGC; * p <0.05, *** p <0.001, **** p <0.0001. n =18 biologically independent samples. Two-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (G) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD + (unswitched memory (USM)), CD19 + CD27 + IgD - , and CD19 + CD27 - IgD - (double negative (DN)) B cells within tumor-infiltrating CD19 + TGFβ + B cells, ex vivo and following 72h stimulation with R848 or CpGC; ** p <0.01, **** p <0.0001. n =12 biologically independent samples. Two-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (H) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells within tumor-infiltrating CD19 + TGFβ + B cells, ex vivo and following 72h stimulation with R848 or CpGC; *** p <0.001, **** p <0.0001. n =11 biologically independent samples. Two-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM.

    Journal: bioRxiv

    Article Title: Tumor-infiltrating CD27 - IgD - regulatory B cells suppress cytotoxic CD8 + T cell responses in renal cell carcinoma

    doi: 10.1101/2025.07.08.663720

    Figure Lengend Snippet: (A) Radar plot showing the Human Molecular Signatures Database and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched in each tumor-infiltrating B cell (TIB) cluster. (B) Density UMAPs showing the distribution of TLR7 hi , TLR9 hi , MYD88 hi , IRAK1 hi , IRAK4 hi , TRAF6 hi , MAP3K7 hi , and NFKB1 hi RCC-resident B cells. (C) Representative contour plots and cumulative data showing IL-10 expression by tumor-infiltrating CD19 + B cells ex vivo (white) and following 72h stimulation with R848 (light grey) or CpGC (dark grey); ** p <0.01, *** p <0.001. For ex vivo n =16, R848 and CpGC n =22 biologically independent samples. Mixed-effects one-way ANOVA with Dunnett’s test for multiple comparisons. Error bars represented as mean±SEM. (D) Representative contour plots and cumulative data showing TGFβ expression by tumor-infiltrating CD19 + B cells ex vivo (white) and following 72h stimulation with R848 (light grey) or CpGC (dark grey); * p <0.05, ** p <0.01. For ex vivo n =13, R848 and CpGC n =10 biologically independent samples. One-way Fridman test with Dunn’s test for multiple comparisons. Error bars represented as mean±SEM. (E) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD + (unswitched memory (USM)), CD19 + CD27 + IgD - , and CD19 + CD27 - IgD - (double negative (DN)) B cells within tumor-infiltrating CD19 + IL-10 + B cells, ex vivo and following 72h stimulation with R848 or CpGC; * p <0.05, ** p <0.01, **** p <0.0001. n =24 biologically independent samples. Two-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (F) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells within tumor-infiltrating CD19 + IL-10 + B cells, ex vivo and following 72h stimulation with R848 or CpGC; * p <0.05, *** p <0.001, **** p <0.0001. n =18 biologically independent samples. Two-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (G) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD + (naive), CD19 + CD27 + IgD + (unswitched memory (USM)), CD19 + CD27 + IgD - , and CD19 + CD27 - IgD - (double negative (DN)) B cells within tumor-infiltrating CD19 + TGFβ + B cells, ex vivo and following 72h stimulation with R848 or CpGC; ** p <0.01, **** p <0.0001. n =12 biologically independent samples. Two-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM. (H) Representative contour plots and cumulative data showing the frequencies of CD19 + CD27 - IgD - CD21 + CD11c - (DN1), CD19 + CD27 - IgD - CD21 - CD11c + (DN2), CD19 + CD27 - IgD - CD21 - CD11c - (DN3) and CD19 + CD27 - IgD - CD21 + CD11c + (DN4) B cells within tumor-infiltrating CD19 + TGFβ + B cells, ex vivo and following 72h stimulation with R848 or CpGC; *** p <0.001, **** p <0.0001. n =11 biologically independent samples. Two-way ANOVA with Tukey’s test for multiple comparisons. Error bars represented as mean±SEM.

    Article Snippet: Tissue-resident B cells were isolated using the EasySep immunomagnetic CD19 positive selection kit (STEMCELL, cat. no. 17854).

    Techniques: Expressing, Ex Vivo